Heartburn

Ohio AG Leads Charge in Major Class-Action Lawsuit Against Pharmaceutical Giant Over Hidden Cancer Risks in Popular Heartburn Medication

by

COLUMBUS, Ohio — Attorney General Dave Yost of Ohio is spearheading efforts to lead a class-action lawsuit that targets the pharmaceutical giant GSK, previously known as GlaxoSmithKline, over allegations of hiding cancer risks associated with its heartburn medication Zantac. The litigation focuses on purported investor losses and claims of misleading information regarding the drug’s safety. On Monday, Yost filed a motion proposing that the Ohio Public Employees Retirement System (OPERS) join forces with the Indiana Public Retirement System as co-lead plaintiffs in the lawsuit. This legal action follows reports that OPERS suffered a considerable financial … Read more

Landmark Hearing Begins as Plaintiffs Allege Cancer Caused by Zantac, Raising Validity Questions for Popular Heartburn Medication

by

Wilmington, Delaware – A Delaware Superior Court judge is set to preside over a case today involving plaintiffs who allege that the popular heartburn medication Zantac caused their cancer. The judge’s main task will be to determine the validity of the methodologies used to establish a connection between this widely-used antacid and certain types of cancer. If the methodologies are deemed valid, the lawsuits against the drug maker will proceed to trial. The lawsuits claim that Zantac, which was discontinued globally by its manufacturer in September 2019 due to concerns about a potentially cancer-causing chemical … Read more